Management of mild pre-eclampsia

Pre-Eclampsia: Etiology and Clinical Practice

Volumn , Issue , 2007, Pages 357-368

  Glanville, Tracey ^a   Walker, James J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928292648     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545634.025     Document Type: Chapter

References (69)

1. Banks, E. H. and Miller, D. A. (1999). Perinatal risks associated with borderline amniotic fluid index. Am. J. Obstet. Gynecol., 180(6 Pt. 1), 1461–3.
2. Barton, J. R., Stanziano, G. J., et al. (1994). Monitored outpatient management of mild gestational hypertension remote from term. Am. J. Obstet. Gynecol., 170(3), 765–9.
3. Barton, J. R., Bergauer, N. K., et al. (1997). Does advanced maternal age affect pregnancy outcome in women with mild hypertension remote from term? Am. J. Obstet. Gynecol., 176(6), 1236–40; discussion 1240–3.
4. Barton, C. B., Barton, J. R., et al. (2002). Mild gestational hypertension: differences in ethnicity are associated with altered outcomes in women who undergo outpatient treatment. Am. J. Obstet. Gynecol., 186(5), 896–8.
5. Begum, F. and Buckshee, K. (1998). Foetal compromise by spontaneous foetal heart rate deceleration in reactive non-stress test and decreased amniotic fluid index.Bangl. Med. Res. Council Bull., 24(3), 60–6.
6. Bergel, E., Carroli, G., et al. (2002). Ambulatory versus conventional methods for monitoring blood pressure during pregnancy. Cochrane Database of Systematic Reviews (2); CD001231.
7. Biswas, A., Choolani, M. A., et al. (1997). Ambulatory blood pressure monitoring in pregnancy induced hypertension.Acta Obstet. Gynecol. Scand., 76(9), 829–33.
8. Brown, M. A. (1995). The physiology of pre-eclampsia.Clin. Exp. Pharmacol. Physiol., 22(11), 781–91.
9. Brown, M. A., Robinson, A., et al. (1998). Ambulatory blood pressure monitoring in pregnancy: what is normal? Am. J. Obstet. Gynecol., 178(4), 836–42.
10. Ceron-Mireles, P., Harlow, S. D., et al. (2001). Risk factors for pre-eclampsia/eclampsia among working women in Mexico City. Paed. Perinat. Epidemiol., 15(1), 40–6.
11. Chandran, R., Serra-Serra, V., et al. (1993). Fetal cerebral Doppler in the recognition of fetal compromise. Br. J. Obstet. Gynaecol., 100(2), 139–44.
12. Crowther, C. A., Bouwmeester, A. M., et al. (1992). Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br. J. Obstet. Gynaecol., 99(1), 13–17.
13. Cruickshank, D. J., Robertson, A. A., et al. (1992). Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study. Eur. J. Obstet. Gynecol. Reprod. Biol., 45(1), 47–51.
14. Davey, D. A. and MacGillivray, I. (1988). The classification and definition of the hypertensive disorders of pregnancy.Am. J. Obstet. Gynecol., 158(4), 892–8.
15. Duley, L., Carroli, G., et al. (1995). Which anticonvulsant for women with eclampsia – evidence from the collaborative eclampsia trial. Lancet, 345, 1455–63.
16. Duley, L., Gulmezoglu, A. M., et al. (2003). Magnesium sulphate and other anticonvulsants for women with preeclampsia.Cochrane Database Syst Rev (2): CD000025.
17. Ellison, G. T. and Holliday, M. (1997). The use of maternal weight measurements during antenatal care. A national survey of midwifery practice throughout the United Kingdom. J. Eval. Clin. Pract., 3(4), 303–17.
18. Ferrazzani, S., Caruso, A., et al. (1990). Proteinuria and outcome of 444 pregnancies complicated by hypertension.Am. J. Obstet. Gynecol., 162(2), 366–71.
19. Gonzalez, A. L., Ulloa Galvan, G., et al. (2000). Risk factors for preeclampsia. Multivariate analysis. Ginecol. Obstet. Mex., 68, 357–62.
20. Halligan, A., Shennan, A., et al. (1996). Diurnal blood pressure difference in the assessment of preeclampsia.Obstet. Gynecol., 87(2), 205–8.
21. Harrington, K. F., Campbell, S., et al. (1991). Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation. Eur. J. Obstet. Gynecol. Reprod. Biol., 42(Suppl.), S14–20.
22. Higgins, J. R., Walshe, J. J., et al. (1997). Can 24-hour ambulatory blood pressure measurement predict the development of hypertension in primigravidae? Br. J. Obstet. Gynaecol., 104(3), 356–62.
23. Hofstaetter, C., Gudmundsson, S., et al. (2002). Venous Doppler velocimetry in the surveillance of severely compromised fetuses. Ultrasound Obstet. Gynecol., 20(3), 233–9.
24. Krauss, T., Emons, G., et al. (2002). Predictive value of routine circulating soluble endothelial cell adhesion molecule measurements during pregnancy. Clin. Chem., 48(9), 1418–25.
25. Leung, K. Y., Sum, T. K., et al. (1998). Is in-patient management of diastolic blood pressure between 90 and 100mmHg during pregnancy necessary? Hong Kong Med. J., 4(2), 211–17.
26. Lindow, S. W. and Davey, D. A. (1992). The variability of urinary protein and creatinine excretion in patients with gestational proteinuric hypertension. Br. J. Obstet. Gynaecol., 99(11), 869–72.
27. Livingston, J. C., Livingston, L. W., et al. (2003). Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial. Obstet. Gynecol., 101(2), 217–20.
28. Magann, E. F., Kinsella, M. J., et al. (1999). Does an amniotic fluid index of –5cm necessitate delivery in high-risk pregnancies? A case-control study. Am. J. Obstet. Gynecol., 180(6 Pt. 1), 1354–9.
29. Magee, L. A. (2001). Treating hypertension in women of child-bearing age and during pregnancy. Drug Safety, 24(6), 457–74.
30. Magee, L. A. and Duley, L. (2000). Oral beta-blockers for mild to moderate hypertension during pregnancy.Cochrane Database Syst. Rev. (4): CD002863.
31. Magee, L. A., Ornstein, M. P., et al. (1999). Fortnightly review: management of hypertension in pregnancy.Br. Med. J., 318(7194), 1332–6.
32. Manning, F. A., Morrison, I., et al. (1982). Antepartum determination of fetal health: composite biophysical profile scoring. Clin. Perinatol., 9(2), 285–96.
33. Mathews, D. D., Patel, I. E., et al. (1971). Outpatient management of toxaemia. J. Obstet. Gynaecol. Br. Com., 78, 610–14.
34. McCartney, C. P. (1968). Renal morphology and function among patients with preeclampsia and gravidas with essential hypertension. Clin. Obstet. Gynecol., 11, 506–21.
35. Meyer, W. J., Gauthier, D., et al. (1994). Ultrasonographic detection of abnormal fetal growth with the gestational age-independent, transverse cerebellar diameter/abdominal circumference ratio. Am. J. Obstet. Gynecol., 171(4), 1057–63.
36. Missfelder-Lobos, H., Teran, E., et al. (2002). Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstet. Gynecol., 19(5), 443–8.
37. Muller, P. R. and James, A. (2002). Pregnancy with prolonged fetal exposure to an angiotensin-converting enzyme inhibitor. J. Perinatol., 22(7), 582–4.
38. Murray, N., Homer, C. S., et al. (2002). The clinical utility of routine urinalysis in pregnancy: a prospective study.Med. J. Aust., 177(9), 477–80.
39. Natarajan, P., Shennan, A. H., et al. (1999). Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia.Am. J. Obstet. Gynecol., 181(5 Pt. 1), 1203–10.
40. Neilson, J. P. and Alfirevic, Z. (2000). Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database Syst. Rev.(2): CD000073.
41. O’Brien, J. M., Mercer, B. M., et al. (1993). Amniotic fluid index in hospitalized hypertensive patients managed expectantly. Obstet. Gynecol., 82(2), 247–50.
42. Ounsted, M., Moar, V., et al. (1980). Infant growth and development following treatment of maternal hypertension.Lancet, 1, 705.
43. Pattison, N. and McCowan, L. (2000). Cardiotocography for antepartum fetal assessment. Cochrane Database of Syst. Rev. (2): CD001068.
44. Penny, J. A., Halligan, A. W., et al. (1998). Automated, ambulatory, or conventional blood pressure measurement in pregnancy: which is the better predictor of severe hypertension? Am. J. Obstet. Gynecol., 178(3), 521–6.
45. Pickering, T. G. (1993). Blood pressure variability and ambulatory monitoring. Curr. Opin. Nephrol. Hypertens., 2(3), 380–5.
46. Pickles, C. J., Broughton Pipkin, F., et al. (1992). A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension. Br. J. Obstet. Gynaecol., 99(12), 964–8.
47. Redman, C. W. G., Williams, G. F., et al. (1977). Plasma urate and serum deoxycytidylate deaminase measurements for the early diagnosis of pre-eclampsia. Br. J. Obstet. Gynaecol., 84, 904–8.
48. Redman, C., Bonnar, J., et al. (1978). Early platelet consumption in pre-eclampsia. Br. Med. J., 1, 467–9.
49. Ries, A., Kopelman, J. N., et al. (2000). Laboratory testing for preeclampsia: result trends and screening recommendations.Mil. Med., 165(7), 546–8.
50. Rosenberg, K. and Twaddle, S. (1990). Screening and surveillance of pregnancy hypertension – an economic approach to the use of daycare. Baill. Clin. Obstet. Gynaecol., 4(1), 89–107.
51. Severi, F. M., Bocchi, C., et al. (2002). Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound in Obstet. Gynecol., 19(3), 225–8.
52. Thadhani, R., Stampfer, M. J., et al. (1999). High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet. Gynecol., 94(4), 543–50.
53. The Magpie Trial Collaboration (2002). Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet, 359(9321), 1877–90.
54. Tomlinson, A. J., Campbell, J., et al. (2000). Malignant primary hypertension in pregnancy treated with lisinopril.Ann. Pharmacotherapy, 34(2), 180–2.
55. Tuffnell, D. J., Lilford, R. J., et al. (1992). Randomised controlled trial of day care for hypertension in pregnancy.Lancet, 339(8787), 224–7.
56. Twaddle, S. and Harper, V. (1992). An economic evaluation of daycare in the management of hypertension in pregnancy. Br. J. Obstet. Gynaecol., 99, 459–63.
57. Venkat-Raman, N., Backos, M., et al. (2001). Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet. Gynecol., 98(2), 235–42.
58. Visser, W. and Wallenburg, H. C. (1995). Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term. Eur. J. Obstet. Gynecol. Reprod. Biol., 63(2), 147–54.
59. Voto, L. S., Illia, R., et al. (1988). Uric acid levels: a useful index of the severity of preeclampsia and perinatal prognosis. J. Perinat. Med., 16(2), 123–6.
60. Wald, N. J. and Morris, J. K. (2001). Multiple marker second trimester serum screening for pre-eclampsia.J. Med. Screen., 8(2), 65–8.
61. Walker, J. J. (1987). The case for early recognition and intervention in pregnancy induced hypertension.Hypertension in Pregnancy. Proceedings Sixteenth Study Group of the Royal College of Obstetricians and Gynaecologists, ed. F. Sharp and E. M. Symonds. New York: Perinatology Press, pp. 289–99.
62. Walker, J. J. (1991). Hypertensive drugs in pregnancy. Antihypertension therapy in pregnancy, preeclampsia, and eclampsia. Clin. Perinatol., 18(4), 845–73.
63. Walker, J. J. (1993). Day care obstetrics. Br. J. Hosp. Med., 50(5), 225–6.
64. Walker, J. J. (2000). Pre-eclampsia. Lancet, 356(9237), 1260–5.
65. Walker, J. J. (2003). Stepwise management. In Preeclampsia, ed. H. Critchley, A. MacLean, L. Poston and J. Walker. London, RCOG, pp. 370–386.
66. Walker, J. J., Cameron, A. D., et al. (1989). Can platelet volume predict progressive hypertensive disease in pregnancy? Am. J. Obstet. Gynecol., 161(3), 676–9.
67. Waugh, J., Bosio, P., et al. (2001). Homemonitoring of blood pressure in pregnancy at high risk of pre-eclampsia.Eur. J. Obstet. Gynecol. Reprod. Biol., 99(1), 109–11.
68. Weinstein, L. (1982). Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am. J. Obstet. Gynecol., 142(2), 159–67.
69. Xenakis, E. M., Piper, J. M., et al. (1997). Preeclampsia: is induction of labor more successful? Obstet. Gynecol., 89(4), 600–3.